Oxilofrine

This page shows anti-doping rule violation data we have registered for Oxilofrine.

Number of cases in Oxilofrine Last 10 Years

Oxilofrine

Oxilofrine ranks #67 globally among prohibited substances, with 46 registered cases (0.3% of all violations) among all sports tracked by the Anti-Doping Database, which contains 14,670 verified cases. Russia leads with 5 cases, while Track and field is the most affected sport (10 cases).

Cases of Oxilofrine by Sport
Track and field
10
Cycling
7
Weightlifting
7
Rugby
3
Powerlifting
3
Top Sport: Track and field

10

Track and field cases

0%

Of all violations

46

Total Oxilofrine cases
Track and field's share of Oxilofrine violations 0%
10 of 46

Track and field has the most recorded cases of Oxilofrine violations globally, with 10 registered cases — 0% of all 46 verified cases.

Cases of Oxilofrine by Country
Russia
5
Switzerland
4
Spain
3
Mexico
3
Poland
2
Top Country: Russia

5

Russia cases

10.9%

Of all violations

46

Total Oxilofrine cases
Russia's share of Oxilofrine violations 10.9%
5 of 46

Russia leads in Oxilofrine violations globally, with 5 registered cases — 10.9% of all 46 verified cases.

Global Substance Ranking

Oxilofrine ranks #67 of 358 prohibited substances in the Anti-Doping Database.

#1 Stanozolol
1,359
#2 Methandienone
833
#3 Norandrosterone
778
#4 Testosterone
758
···
#67 Oxilofrine
46
About This Ranking

This ranking covers only prohibited substances with verified case records in the Anti-Doping Database. Procedural violations (whereabouts failures, refusals to test, etc.) are excluded.

Active Sanctions — Expiry Year
Gender Distribution
Male 69.6%
32 cases
Female 30.4%
14 cases
Analysis: shows an unusually high proportion of female cases (30.4%) compared to the global average (19.8%), a difference of 10.6 percentage points. Global average: 80.2% male, 19.8% female
Average Suspension Length
24.5
months
Oxilofrine
30.1
months
Global average

The average suspension for Oxilofrine violations is 24.5 months, shorter than the global average of 30.1 months.

Oxilofrine (also known as Methylsynephrine, Hydroxyephrine, Oxyephrine, and 4-HMP) is a stimulant drug related chemically to ephedrine and to synephrine. Classical pharmacological studies on animals and isolated animal tissues showed that the principal actions of parenterally-administered synephrine included raising blood-pressure, dilating the pupil, and constricting peripheral blood vessels. (Source: wikipedia)

If you use this data, please credit The Anti-Doping Database

The intelligence tool for anti-doping professionals

Used by journalists, sport lawyers, NADOs and researchers worldwide for proactive strategy — not just post-case research.

 

As a subscriber you get instant access to verified, structured anti-doping case data — from hours of research to seconds:

  • Complete athlete and sanction details
    • Identity, ban periods, substances used, test type, violation information and more.
  • Verified documents and case materials
    • Access sanction decisions, PDFs and official sources when available.
  • Advanced insights and historical trends
    • Statistics across sports, countries, substances and year-by-year comparisons — for proactive planning, not just post-case analysis.

The Anti-Doping Database currently contains 14,670 verified anti-doping rule violations across all sports and all countries, and is updated regularly.